Beijing SL Pharmaceutical Co Ltd Free Cash Flow Generation Index
Beijing SL Pharmaceutical Co Ltd free cash flow generation index. Beijing SL Pharmaceutical Co Ltd (002038) has a Free Cash Flow Generation Index of 0.83x as of September 2025. Free cash flow of CN¥55.21 Million represents 1% of operating cash flow (CN¥66.55 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Beijing SL Pharmaceutical Co Ltd (2003–2025)
Free cash flow generation index of Beijing SL Pharmaceutical Co Ltd from 2003 to 2025. Historical FCF Generation Index trend for Beijing SL Pharmaceutical Co Ltd across 23 annual periods. See Beijing SL Pharmaceutical Co Ltd (002038) flexibility index to measure the company's free cash flow as a share of total liabilities.
Beijing SL Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (2003–2025)
Beijing SL Pharmaceutical Co Ltd free cash flow generation index by year from 2003 to 2025. Year-by-year Free Cash Flow Generation Index for Beijing SL Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Beijing SL Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥64.69 Million | CN¥257.66 Million | CN¥192.97 Million | ▲ +146.4% |
| 2024 | -0.54x | CN¥-121.89 Million | CN¥225.49 Million | CN¥347.38 Million | ▼ -202.9% |
| 2023 | 0.53x | CN¥241.84 Million | CN¥460.20 Million | CN¥218.36 Million | ▼ -9.5% |
| 2022 | 0.58x | CN¥226.33 Million | CN¥389.82 Million | CN¥163.49 Million | ▲ +18.5% |
| 2021 | 0.49x | CN¥227.72 Million | CN¥464.63 Million | CN¥236.91 Million | ▲ +27.5% |
| 2020 | 0.38x | CN¥159.89 Million | CN¥415.84 Million | CN¥255.95 Million | ▼ -34.9% |
| 2019 | 0.59x | CN¥393.04 Million | CN¥665.83 Million | CN¥272.78 Million | ▲ +11.1% |
| 2018 | 0.53x | CN¥257.80 Million | CN¥485.17 Million | CN¥227.37 Million | ▲ +33.9% |
| 2017 | 0.40x | CN¥151.08 Million | CN¥380.72 Million | CN¥229.65 Million | ▼ -32.3% |
| 2016 | 0.59x | CN¥232.65 Million | CN¥396.86 Million | CN¥164.21 Million | ▼ -21.1% |
| 2015 | 0.74x | CN¥375.19 Million | CN¥504.87 Million | CN¥129.68 Million | ▲ +10.1% |
| 2014 | 0.68x | CN¥313.99 Million | CN¥465.00 Million | CN¥151.01 Million | ▼ -1.4% |
| 2013 | 0.68x | CN¥237.94 Million | CN¥347.41 Million | CN¥109.48 Million | ▲ +81.1% |
| 2012 | 0.38x | CN¥150.70 Million | CN¥398.60 Million | CN¥247.89 Million | ▼ -44.4% |
| 2011 | 0.68x | CN¥155.54 Million | CN¥228.59 Million | CN¥73.05 Million | ▼ -16.9% |
| 2010 | 0.82x | CN¥195.09 Million | CN¥238.13 Million | CN¥43.04 Million | ▼ -0.7% |
| 2009 | 0.83x | CN¥143.95 Million | CN¥174.41 Million | CN¥30.46 Million | ▼ -6.0% |
| 2008 | 0.88x | CN¥170.71 Million | CN¥194.32 Million | CN¥23.61 Million | ▲ +25.7% |
| 2007 | 0.70x | CN¥61.75 Million | CN¥88.36 Million | CN¥26.61 Million | ▲ +644.0% |
| 2006 | -0.13x | CN¥-7.39 Million | CN¥57.55 Million | CN¥64.95 Million | ▲ +81.9% |
| 2005 | -0.71x | CN¥-33.76 Million | CN¥47.48 Million | CN¥81.24 Million | ▼ -264.3% |
| 2004 | 0.43x | CN¥13.53 Million | CN¥31.26 Million | CN¥17.73 Million | ▼ -6.4% |
| 2003 | 0.46x | CN¥14.12 Million | CN¥30.55 Million | CN¥16.43 Million | — |